ABBOTT AXSYM HBSAG

FDA Premarket Approval P050049 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for labeling modifications that clarifies the meaning of the final interpretation repeat reactive, nonconforming for hbsag in the axsym hbsag confirmatory package insert. Also, changes to the axsym hbsag package insert to align with the removal of the term "repeat reactive" from the interpretation of results for the axsym hbsag confirmatory assays.

DeviceABBOTT AXSYM HBSAG
Generic NameTest, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm)
ApplicantABBOTT LABORATORIES INC
Date Received2007-12-13
Decision Date2007-12-19
PMAP050049
SupplementS002
Product CodeLOM 
Advisory CommitteeMicrobiology
Supplement TypeSpecial (immediate Track)
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT LABORATORIES INC 100 Abbott Park Road dept 9va- Ap8-1 abbott Park, IL 60064

Supplemental Filings

Supplement NumberDateSupplement Type
P050049Original Filing
S011 2012-11-13 30-day Notice
S010 2012-02-06 30-day Notice
S009 2011-11-02 135 Review Track For 30-day Notice
S008 2011-08-01 135 Review Track For 30-day Notice
S007 2011-06-10 30-day Notice
S006 2011-01-31 Normal 180 Day Track No User Fee
S005 2010-11-01 Normal 180 Day Track No User Fee
S004 2010-09-27 30-day Notice
S003 2008-10-24 Real-time Process
S002 2007-12-13 Special (immediate Track)
S001 2007-01-17 30-day Notice

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.